In today’s rapidly evolving world of digital innovation, the intersection of technology and healthcare is not just reshaping medical care, it’s redefining it. From AI-powered diagnostics to big data-driven decision-making, digital health solutions are accelerating a patient-centered transformation in medical care.
At 4YFN25 - MWC25, AstraZeneca will lead a half-day session dedicated to exploring how startups, big data and AI applied to Healthcare Information Technologies, and cutting-edge digital solutions are unlocking new opportunities for patients, healthcare professionals, and health systems worldwide.
AstraZeneca’s Digital Health Innovation Agenda at 4YFN25
? March 4, 2025 | ? 4YFN – Hall 8.0, Sky Stage
The agenda features a series of insightful discussions highlighting real-world applications of digital health innovation.
? 15:00 - 15:10 | Forging the Future of Healthcare Innovation
The session begins with a bold vision: leveraging technology for transforming care and building a healthier future. AstraZeneca’s commitment to digital transformation goes beyond advancing medicine, it is about co-creating sustainable solutions with startups, healthcare systems, and the broader innovation ecosystem to drive lasting impact.
? 15:10 - 15:30 | Innovation with Purpose: Making Digital Health Meaningful
Technology is a powerful tool, but its real impact depends on how we use it. This session explores real-world digital health solutions that are already improving patient outcomes, reducing inefficiencies, and enabling a more sustainable healthcare system.
? 15:30 - 16:00 | Evolving Chronic Patient Care: Analysis and Solutions in Primary Care as a Driver of Change
Chronic diseases present a major challenge to healthcare sustainability. How can remote monitoring, AI-based risk prediction, and digital tools empower primary care professionals to detect, manage, and even prevent conditions like asthma, COPD, and cardio-renal diseases?
? 16:00 - 16:30 | Breathing the Future: Digital Innovation in Preventive Respiratory Health
The future of respiratory care lies in early detection, prevention, and personalized treatments. We will explore how machine learning, digital biomarkers, and AI-driven risk models are transforming the way we approach lung diseases and respiratory health, ensuring more efficient resource utilization.
? 16:30 - 17:00 | Revolutionizing Diagnosis: The Electronic Health Record as a Catalyst for Change
Electronic Health Records (EHRs) are more than just digital documentation, they are the foundation for data-driven decision-making, predictive analytics, and personalized medicine. This panel will explore how advancements in Healthcare Information Systems, from everyday clinical applications to AI-powered EHR integration, are transforming diagnosis in cardiovascular, renal, and metabolic diseases. By enhancing precision and optimizing resource use, these innovations are driving more efficient and effective care for CAREME patients.
? 17:30 - 17:50 | Big Data & Deep Learning: The New DNA of Diagnosis
AI is revolutionizing diagnostics. From predicting cardiovascular risk to automating complex imaging analysis, this session highlights how startups and digital health pioneers are unlocking the next generation of diagnostic solutions, improving accuracy while reducing the burden on healthcare systems.
? 17:50 - 18:20 | Disrupting Oncology: AI, Precision Medicine & Next-Gen Technologies
How is AI transforming cancer detection and treatment? A world-class panel of startups and industry experts will explore the latest advancements in biomarker discovery, digital pathology, and AI-driven oncology solutions, focusing on scalability and long-term impact.
? 18:20 - 18:45 | Digital Transformation in Oncology Diagnosis
Advances in computational pathology and AI-powered biomarkers are taking cancer diagnostics to the next level. This session will highlight how AI-driven insights are improving early detection, treatment selection, and patient outcomes, making oncology care more proactive and effective.
Rick Suárez, President of AstraZeneca Spain, highlights the significance of this collaboration:
"The future of healthcare will be defined by the convergence of technology, science, and strategic collaboration. Events like 4YFN25 - MWC25 are a catalyst for this transformation- bringing together pioneers who are redefining patient care through digital innovation. At AstraZeneca, we are committed to harnessing cutting-edge technologies and bold partnerships to accelerate a more predictive, personalized, and integrated healthcare system that improves lives worldwide.”
Co-Creating the Future of Sustainable Healthcare
The 4YFN ecosystem is where bold ideas meet real-world impact. AstraZeneca is committed to partnering with startups, researchers, healthcare professionals, and tech disruptors to accelerate the adoption of digital solutions that will shape the future of medicine in a way that is scalable, sustainable, and beneficial to all stakeholders.
If you are a startup, entrepreneur, or health tech innovator looking to scale your impact, we invite you to join us at 4YFN25 - MWC25. Let’s build a healthier, more connected, and more efficient healthcare system, together.
To get more information about the Digital Health Programme at 4YFN25 visit our website here.
See you at 4YFN25!